BDBM352196 3-{4-[5-Amino-4-(6- morpholin-4-ylmethyl-1H- indole-2-carbonyl)-pyrazol- 1-yl]-3-chloro-phenoxy}- benzonitrile::US9802920, Compound I-20
SMILES: NCc1cccc(Oc2ccc(c(Cl)c2)-n2ncc(C(=O)c3cc4ccc(CN5CCOCC5)cc4[nH]3)c2N)c1
InChI Key: InChIKey=XLSVPGNFNKEVJA-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tyrosine-protein kinase BTK (Homo sapiens (Human)) | BDBM352196 (3-{4-[5-Amino-4-(6- morpholin-4-ylmethyl-1H- indol...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffman-La Roche Inc.; Chugai Pharamceutical Co. US Patent | Assay Description This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (Förster/Flouresence... | US Patent US9802920 (2017) BindingDB Entry DOI: 10.7270/Q29G5PXH | |||||||||||
More data for this Ligand-Target Pair |